Skip to content

Iron-Biofortified Rice Intervention in the Philippines

Randomized Trial of Iron-Biofortified Rice in Women in the Philippines

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04623918
Enrollment
288
Registered
2020-11-10
Start date
2002-06-01
Completion date
2003-12-31
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron-deficiency

Keywords

Anemia, Iron, Biofortification, Philippines, Iron deficiency, Women of reproductive age

Brief summary

The objective of this randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified rice on iron status in women, compared to non-biofortified rice. A randomized trial of biofortified rice (IR68144-2B-2-2-3), bred to enhance iron content, was conducted among women living in convents in the greater area of Manila, Philippines for 9 months.

Detailed description

Iron deficiency is the most prevalent nutritional deficiency globally, with the highest burden in women of reproductive age and children. In this randomized controlled trial, 317 women aged 18-45 years living in convents in the greater Manila area, Philippines, were fed meals using either biofortified or commercially available rice for all meals, 7 days a week, for 9 months. Women living in convents in the greater Manila area were recruited for this study. These women represent a segment of the population at high risk for iron deficiency, consume large quantities of rice, and all of their meals are prepared and consumed in common kitchen and dining areas, respectively. The investigators hypothesized that daily consumption of iron-biofortified rice (IR68144-2B-2-2-3) would improve hemoglobin, serum ferritin, and total body iron in 9 months, compared to control rice. In order to examine this hypothesis, the investigators conducted a randomized efficacy trial of iron-biofortified rice and iron status in among women living in convents in the greater area of Manila, Philippines for 9 months. The objective of this randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified rice on iron status in women, compared to non-biofortified rice. The long-term goal of this study is to determine if iron bio-fortification of rice is an efficacious and potentially effective strategy to improve iron status of at-risk populations in resource-limited settings.

Interventions

OTHERIron-biofortified rice

Iron-biofortified rice (IR68144-2B-2-2-3)

OTHERControl rice

Control rice (C4), identical in appearance

Sponsors

Penn State University
CollaboratorOTHER
University of the Philippines
CollaboratorOTHER
Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Masking description: The study was a double-blind, randomized controlled trial of; (1) iron-biofortified rice (IR68144-2B-2-2-3), compared to (2) a commercially available variety of rice (C4), with the intervention randomized at the individual level. Administrators, participants, research staff (i.e. responsible for daily data collection and preparation of rice for all meals, assessment of outcomes), and laboratory staff were blinded to the intervention group.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Women (18-45 years old) living in convents in the greater Manila area * Hb ≥10.5 g/dL

Exclusion criteria

* Current or history of gastrointestinal or hematological disorders * Taking iron supplements or medications that could interfere with hematopoiesis or dietary iron absorption * Hb \<10.5 g/dL * Women expressed uncertainty in their ability to participate for the full (9 month) trial

Design outcomes

Primary

MeasureTime frameDescription
Change in serum ferritin9 monthsSerum ferritin (SF)
Change in sTfR9 monthsSoluble transferrin receptor (sTfR)
Change in TBI9 monthsTotal body iron (TBI)

Secondary

MeasureTime frameDescription
Change in hemoglobin among women who were anemic at baseline9 monthsChanges in hemoglobin (Hb) in women who were anemic at baseline
Changes in TBI among women who were non-anemic at baseline9 monthsChanges in TBI among women who were non-anemic at baseline
Changes in SF among women who were non-anemic at baseline9 monthsChanges in SF among women who were non-anemic at baseline
Changes in sTfR among women who were non-anemic at baseline9 monthsChanges in sTfR among women who were non-anemic at baseline

Countries

Philippines

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026